Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Eledon Pharmaceuticals (ELDN) Other Gross PP&E Adjustments (2016 - 2026)

Eledon Pharmaceuticals filings provide 5 years of Other Gross PP&E Adjustments readings, the most recent being -$158000.0 for Q4 2017.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 75.43% to -$158000.0 in Q4 2017 year-over-year; TTM through Dec 2017 was -$1.5 million, a 139.35% decrease, with the full-year FY2017 number at -$158000.0, up 75.43% from a year prior.
  • Other Gross PP&E Adjustments hit -$158000.0 in Q4 2017 for Eledon Pharmaceuticals, up from -$276000.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$158000.0 in Q4 2017 to a low of -$1.1 million in Q1 2017.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$584500.0 (2015), compared with a mean of -$555571.4.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 95.86% in 2014 and later skyrocketed 75.43% in 2017.
  • Eledon Pharmaceuticals' Other Gross PP&E Adjustments stood at -$266000.0 in 2013, then tumbled by 95.86% to -$521000.0 in 2014, then crashed by 37.62% to -$717000.0 in 2015, then grew by 10.32% to -$643000.0 in 2016, then skyrocketed by 75.43% to -$158000.0 in 2017.
  • The last three reported values for Other Gross PP&E Adjustments were -$158000.0 (Q4 2017), -$276000.0 (Q3 2017), and -$1.1 million (Q1 2017) per Business Quant data.